Beese Fulmer Investment Management »

United Therapeutics Corporation shares owned by Beese Fulmer Investment Management

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Beese Fulmer Investment Management from 13F filings

Historical chart of Beese Fulmer Investment Management investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Beese Fulmer Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Beese Fulmer Investment Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $304k 624 487.25

More positions owned by Beese Fulmer Investment Management

Apple (AAPL)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Alphabet Inc Cap Stk Cl A Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Alphabet Inc Cap Stk Cl C Cap Stk Cl C (GOOG)
Mastercard Incorporated Cl A Cl A (MA)
Raytheon Technologies Corp (RTX)
Berkshire Hathaway Inc Del Cl B Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
Johnson & Johnson (JNJ)
TJX Companies (TJX)
O'reilly Automotive (ORLY)
Costco Wholesale Corporation (COST)
Exxon Mobil Corporation (XOM)

View all positions for Beese Fulmer Investment Management

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
venBio Select Advisor
Renaissance Technologies
State Street Corporation
Wellington Management Company
Susquehanna International
Geode Capital Management
AQR Capital Management
Darwin Global Management
LSV Asset Management
Invesco
Assetmark
Caption Management
Dimensional Fund Advisors

View all funds holding United Therapeutics Corporation